Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Insulin Glargine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Insulin Glargine market. Detailed analysis of key players, along with key growth strategies adopted by Insulin Glargine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi-Aventis
Ganlee
Biocon
By Type:
Single Dose Vial
Pre-filled Syringe
By End-User:
Treat type2 diabetes
Treat type1 diabetes
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Insulin Glargine Market
-
1.3 Market Segment by Type
-
1.3.1 USA Insulin Glargine Market Size and Growth Rate of Single Dose Vial from 2016 to 2027
-
1.3.2 USA Insulin Glargine Market Size and Growth Rate of Pre-filled Syringe from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Insulin Glargine Market Size and Growth Rate of Treat type2 diabetes from 2016 to 2027
-
1.4.2 USA Insulin Glargine Market Size and Growth Rate of Treat type1 diabetes from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Insulin Glargine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Insulin Glargine by Major Types
-
3.4.1 Market Size and Growth Rate of Single Dose Vial
-
3.4.2 Market Size and Growth Rate of Pre-filled Syringe
4 Segmentation of Insulin Glargine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Insulin Glargine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Insulin Glargine in Treat type2 diabetes
-
4.4.2 Market Size and Growth Rate of Insulin Glargine in Treat type1 diabetes
5 Market Analysis by Regions
-
5.1 USA Insulin Glargine Production Analysis by Regions
-
5.2 USA Insulin Glargine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Insulin Glargine Landscape Analysis
-
6.1 West USA Insulin Glargine Landscape Analysis by Major Types
-
6.2 West USA Insulin Glargine Landscape Analysis by Major End-Users
7 South USA Insulin Glargine Landscape Analysis
-
7.1 South USA Insulin Glargine Landscape Analysis by Major Types
-
7.2 South USA Insulin Glargine Landscape Analysis by Major End-Users
8 Middle West USA Insulin Glargine Landscape Analysis
-
8.1 Middle West USA Insulin Glargine Landscape Analysis by Major Types
-
8.2 Middle West USA Insulin Glargine Landscape Analysis by Major End-Users
9 Northeast USA Insulin Glargine Landscape Analysis
-
9.1 Northeast USA Insulin Glargine Landscape Analysis by Major Types
-
9.2 Northeast USA Insulin Glargine Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi-Aventis
-
10.1.1 Sanofi-Aventis Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Ganlee
-
10.2.1 Ganlee Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Biocon
-
10.3.1 Biocon Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Insulin Glargine Market Size and Growth Rate of Single Dose Vial from 2016 to 2027
-
Figure USA Insulin Glargine Market Size and Growth Rate of Pre-filled Syringe from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Insulin Glargine Market Size and Growth Rate of Treat type2 diabetes from 2016 to 2027
-
Figure USA Insulin Glargine Market Size and Growth Rate of Treat type1 diabetes from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Insulin Glargine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Insulin Glargine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Insulin Glargine
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Insulin Glargine by Different Types from 2016 to 2027
-
Table Consumption Share of Insulin Glargine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Single Dose Vial
-
Figure Market Size and Growth Rate of Pre-filled Syringe
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Insulin Glargine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Insulin Glargine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Treat type2 diabetes
-
Figure Market Size and Growth Rate of Treat type1 diabetes
-
Table USA Insulin Glargine Production by Regions
-
Table USA Insulin Glargine Production Share by Regions
-
Figure USA Insulin Glargine Production Share by Regions in 2016
-
Figure USA Insulin Glargine Production Share by Regions in 2021
-
Figure USA Insulin Glargine Production Share by Regions in 2027
-
Table USA Insulin Glargine Consumption by Regions
-
Table USA Insulin Glargine Consumption Share by Regions
-
Figure USA Insulin Glargine Consumption Share by Regions in 2016
-
Figure USA Insulin Glargine Consumption Share by Regions in 2021
-
Figure USA Insulin Glargine Consumption Share by Regions in 2027
-
Table West USA Insulin Glargine Consumption by Types from 2016 to 2027
-
Table West USA Insulin Glargine Consumption Share by Types from 2016 to 2027
-
Figure West USA Insulin Glargine Consumption Share by Types in 2016
-
Figure West USA Insulin Glargine Consumption Share by Types in 2021
-
Figure West USA Insulin Glargine Consumption Share by Types in 2027
-
Table West USA Insulin Glargine Consumption by End-Users from 2016 to 2027
-
Table West USA Insulin Glargine Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Insulin Glargine Consumption Share by End-Users in 2016
-
Figure West USA Insulin Glargine Consumption Share by End-Users in 2021
-
Figure West USA Insulin Glargine Consumption Share by End-Users in 2027
-
Table South USA Insulin Glargine Consumption by Types from 2016 to 2027
-
Table South USA Insulin Glargine Consumption Share by Types from 2016 to 2027
-
Figure South USA Insulin Glargine Consumption Share by Types in 2016
-
Figure South USA Insulin Glargine Consumption Share by Types in 2021
-
Figure South USA Insulin Glargine Consumption Share by Types in 2027
-
Table South USA Insulin Glargine Consumption by End-Users from 2016 to 2027
-
Table South USA Insulin Glargine Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Insulin Glargine Consumption Share by End-Users in 2016
-
Figure South USA Insulin Glargine Consumption Share by End-Users in 2021
-
Figure South USA Insulin Glargine Consumption Share by End-Users in 2027
-
Table Middle West USA Insulin Glargine Consumption by Types from 2016 to 2027
-
Table Middle West USA Insulin Glargine Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Insulin Glargine Consumption Share by Types in 2016
-
Figure Middle West USA Insulin Glargine Consumption Share by Types in 2021
-
Figure Middle West USA Insulin Glargine Consumption Share by Types in 2027
-
Table Middle West USA Insulin Glargine Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Insulin Glargine Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Insulin Glargine Consumption Share by End-Users in 2016
-
Figure Middle West USA Insulin Glargine Consumption Share by End-Users in 2021
-
Figure Middle West USA Insulin Glargine Consumption Share by End-Users in 2027
-
Table Northeast USA Insulin Glargine Consumption by Types from 2016 to 2027
-
Table Northeast USA Insulin Glargine Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Insulin Glargine Consumption Share by Types in 2016
-
Figure Northeast USA Insulin Glargine Consumption Share by Types in 2021
-
Figure Northeast USA Insulin Glargine Consumption Share by Types in 2027
-
Table Northeast USA Insulin Glargine Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Insulin Glargine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Insulin Glargine Consumption Share by End-Users in 2016
-
Figure Northeast USA Insulin Glargine Consumption Share by End-Users in 2021
-
Figure Northeast USA Insulin Glargine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi-Aventis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis
-
Figure Sales and Growth Rate Analysis of Sanofi-Aventis
-
Figure Revenue and Market Share Analysis of Sanofi-Aventis
-
Table Product and Service Introduction of Sanofi-Aventis
-
Table Company Profile and Development Status of Ganlee
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ganlee
-
Figure Sales and Growth Rate Analysis of Ganlee
-
Figure Revenue and Market Share Analysis of Ganlee
-
Table Product and Service Introduction of Ganlee
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
